C3G
Clinical trials for C3G explained in plain language.
Never miss a new study
Get alerted when new C3G trials appear
Sign up with your email to follow new studies for C3G, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Breakthrough pill trial offers hope for devastating kidney disease
Disease control Recruiting nowThis study is testing whether a daily pill called iptacopan can help people with a rare and serious kidney disease called C3G. About 98 participants, including teens and adults, will take either iptacopan or a placebo (sugar pill) for up to a year, along with their standard medic…
Matched conditions: C3G
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug trial offers hope for rare kidney disease patients
Disease control Recruiting nowThis study is testing an experimental drug called ADX-038 for adults with specific immune-related kidney diseases. Researchers want to see if the drug is safe and effective at controlling these conditions. The trial will enroll 45 participants who have been diagnosed with disease…
Matched conditions: C3G
Phase: PHASE2 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC